Biotron Valuation
| BITRF Stock | USD 0.01 0.00 0.00% |
Biotron seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Biotron Limited from analyzing the firm fundamentals such as Profit Margin of (1.78) %, return on equity of -1.12, and Current Valuation of 15.31 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Biotron's price fluctuation is out of control at this time. Calculation of the real value of Biotron Limited is based on 3 months time horizon. Increasing Biotron's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Biotron pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Biotron Limited. Since Biotron is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotron Pink Sheet. However, Biotron's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0125 | Real 0.012 | Hype 0.01 | Naive 0.009738 |
The real value of Biotron Pink Sheet, also known as its intrinsic value, is the underlying worth of Biotron Limited Company, which is reflected in its stock price. It is based on Biotron's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Biotron's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Biotron Limited helps investors to forecast how Biotron pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotron more accurately as focusing exclusively on Biotron's fundamentals will not take into account other important factors: Biotron Total Value Analysis
Biotron Limited is currently projected to have takeover price of 15.31 M with market capitalization of 18.67 M, debt of 77.24 K, and cash on hands of 1.74 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biotron fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.31 M | 18.67 M | 77.24 K | 1.74 M |
Biotron Investor Information
About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.0. Biotron Limited had not issued any dividends in recent years. The entity had 140:127 split on the 15th of May 2018. Based on the analysis of Biotron's profitability, liquidity, and operating efficiency, Biotron Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Biotron Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biotron has an asset utilization ratio of 81.77 percent. This implies that the Company is making $0.82 for each dollar of assets. An increasing asset utilization means that Biotron Limited is more efficient with each dollar of assets it utilizes for everyday operations.Biotron Ownership Allocation
Biotron holds a total of 901.94 Million outstanding shares. Biotron Limited shows 14.13 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Biotron Profitability Analysis
The company reported the revenue of 1.56 M. Net Loss for the year was (2.78 M) with profit before overhead, payroll, taxes, and interest of 1.56 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Biotron's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Biotron and how it compares across the competition.
About Biotron Valuation
The pink sheet valuation mechanism determines Biotron's current worth on a weekly basis. Our valuation model uses a comparative analysis of Biotron. We calculate exposure to Biotron's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biotron's related companies.Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Biotron's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biotron's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biotron's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biotron's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biotron's revenue streams: Identify Biotron's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biotron's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biotron's growth potential: Evaluate Biotron's management, business model, and growth potential.
- Determine Biotron's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biotron's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Biotron Growth Indicators
Investing in growth stocks can be very risky. If the company such as Biotron does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 701.9 M | |
| Retained Earnings | -51.8 M |
Complementary Tools for Biotron Pink Sheet analysis
When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |